EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Recommendations for (Pharmaco)Genetic Sampling in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation

Anniek Bokma, Maja Matic, Arwin Ralf, Bianca J C van den Bosch, Manfred Kayser, Ron H N van Schaik, Melvin Lafeber, Marieke J H Coenen, Florence Atrafi

Clinical and Translational Science · 2025-08 · 18 (8)

DOI: 10.1111/cts.70303 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical and Translational Science, online erschienen am 13.08.2025. Verfasst von Anniek Bokma und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Vascular Medicine and Pharmacology, Erasmus MC University Medical Center, Rotterdam, the Netherlands. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Pharmacogenomic Testing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In patients receiving allogenic hematopoietic stem cell transplantation (aHSCT) complete chimerism is desired. However, this brings a challenge when non‐invasive assessment of recipient germline DNA is required for genetic testing. Here, we aim to create awareness for (pharmaco)genetic sampling in patients following aHSCT based on a case report of a patient following aHSCT in which pharmacogenetic analysis was performed. Six pharmacogenetic genes were analyzed in DNA extracted from peripheral blood (pre‐ and post‐transplant), buccal swab, and hair follicles. To investigate the presence of donor DNA in post‐transplant samples, short tandem repeat and digital droplet PCR analysis were performed. DNA from post‐transplantation peripheral blood and the buccal swab showed identical genotypes: CYP2C9 *1/*1, CYP2C19 *1/*2, CYP2D6 *2/*9, CYP3A4 *1/*1, VKORC1 ‐1639TT, SLCO1B1 *1/*5. Pre‐transplant DNA showed different genotypes for CYP2D6 (*1/*2) and SLCO1B1 (*1/*1). Due to the low DNA amount extracted from hair follicles, only CYP2D6 and SLCO1B1 were examined, showing identical genotypes to pre‐transplantation DNA. Short tandem repeat analysis showed that the buccal swab contained DNA from both donor and recipient. It was estimated that the buccal swab contained ~63% donor DNA, while DNA from hair follicles showed 0% donor DNA. In conclusion, pharmacogenetic profiling after allogenic HSCT should be done with consideration. Analysis of pre‐transplant peripheral blood is preferred over buccal swab due to the presence of donor DNA contamination. DNA extracted from hair is also a reliable source; however, application might be restricted due to limited DNA yield.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationPharmacogenomic TestingHumansTransplantation, HomologousMaleFemaleAdultMiddle AgedGenotype

Stichwörter der Autor:innen

allogeneicbuccalhairhematopoietic stem cell transplantationpharmacogeneticssalivasampling

Autor:innen und Institutionen

  • Department of Internal Medicine, Division of Vascular Medicine and Pharmacology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
  • Department of Hospital Pharmacy, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
  • Department of Clinical Chemistry, Erasmus MC University Medical Centre, Rotterdam, the Netherlands.
  • Department of Genetic Identification, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
  • Department of Clinical Genetics, Maastricht University Medical Center+, Maastricht, the Netherlands.

Zitieren

APA

Bokma, A., Matic, M., Ralf, A., van den Bosch, B. J. C., Kayser, M., van Schaik, R. H. N., Lafeber, M., Coenen, M. J. H., & Atrafi, F. (2025). Recommendations for (Pharmaco)Genetic Sampling in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation. Clinical and Translational Science, 18(8). https://doi.org/10.1111/cts.70303

Vancouver

Bokma A, Matic M, Ralf A, van den Bosch BJC, Kayser M, van Schaik RHN, et al. Recommendations for (Pharmaco)Genetic Sampling in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation. Clinical and Translational Science. 2025;18(8). doi:10.1111/cts.70303

BibTeX
@article{Bokma2025,
  author = {Bokma, Anniek and Matic, Maja and Ralf, Arwin and van den Bosch, Bianca J C and Kayser, Manfred and van Schaik, Ron H N and Lafeber, Melvin and Coenen, Marieke J H and Atrafi, Florence},
  title = {Recommendations for (Pharmaco)Genetic Sampling in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation},
  journal = {Clinical and Translational Science},
  year = {2025},
  volume = {18},
  number = {8},
  doi = {10.1111/cts.70303}
}
Kostenlos starten →